Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dold

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Plos One|January 6, 2016
Statistical Evaluation of HTS Assays for Enzymatic Hydrolysis of β-Keto EstersO Buß, S Jager, S-M Dold, et al.
Acta Psychiatrica Scandinavica|March 2, 2018
Clinical correlates of augmentation/combination treatment strategies in major depressive disorderM Dold, L Bartova, J Mendlewicz, et al.
Pharmacological Reviews|June 10, 2018
International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological TargetsF Caraci, F Calabrese, R Molteni, et al.
Leukemia Research|March 13, 2024
Expression of the chemokine receptor CCR1 decreases sensitivity to bortezomib in multiple myeloma cell linesMara N Zeissig, Duncan R Hewett, Krzysztof M Mrozik, et al.
Acta Psychiatrica Scandinavica|October 7, 2018
Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter studyA Kautzky, M Dold, L Bartova, et al.
British Journal of Cancer|August 26, 2004
Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour modelsI K Dev, R E Dornsife, T M Hopper, et al.
Science (New York, N.Y.)|January 6, 2001
Prevention of chemotherapy-induced alopecia in rats by CDK inhibitorsS T Davis, B G Benson, H N Bramson, et al.
Science (New York, N.Y.)|January 16, 2003
RetractionStephen T Davis, Bill G Benson, H Neal Bramson, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Plos One|January 6, 2016
Statistical Evaluation of HTS Assays for Enzymatic Hydrolysis of β-Keto EstersO Buß, S Jager, S-M Dold, et al.
Acta Psychiatrica Scandinavica|March 2, 2018
Clinical correlates of augmentation/combination treatment strategies in major depressive disorderM Dold, L Bartova, J Mendlewicz, et al.
Pharmacological Reviews|June 10, 2018
International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological TargetsF Caraci, F Calabrese, R Molteni, et al.
Leukemia Research|March 13, 2024
Expression of the chemokine receptor CCR1 decreases sensitivity to bortezomib in multiple myeloma cell linesMara N Zeissig, Duncan R Hewett, Krzysztof M Mrozik, et al.
Acta Psychiatrica Scandinavica|October 7, 2018
Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter studyA Kautzky, M Dold, L Bartova, et al.
British Journal of Cancer|August 26, 2004
Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour modelsI K Dev, R E Dornsife, T M Hopper, et al.
Science (New York, N.Y.)|January 6, 2001
Prevention of chemotherapy-induced alopecia in rats by CDK inhibitorsS T Davis, B G Benson, H N Bramson, et al.
Science (New York, N.Y.)|January 16, 2003
RetractionStephen T Davis, Bill G Benson, H Neal Bramson, et al.
Pageof 3